‘Angiotensin hypothesis’ : angiotensin-II stimulating antihypertensives linked to lower dementia risk


  • Angiotensin-II-stimulating antihypertensive use is associated with a 40% lower risk of incident dementia compared with angiotensin-II-inhibiting antihypertensive use.

Why this matters ?

    The beneficial effects associated with angiotensin-II-stimulating antihypertensives may have major implications for clinical practice. These hypertensives could provide a treatment regimen that is easy and cheap to implement on a large scale which would reduce dementia risk.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.